Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
30,273,764
-
Total 13F shares
-
13,713,806
-
Share change
-
+682,541
-
Total reported value
-
$258,404,333
-
Price per share
-
$19.14
-
Number of holders
-
52
-
Value change
-
+$11,041,962
-
Number of buys
-
21
-
Number of sells
-
21
Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) as of Q3 2024
As of 30 Sep 2024,
Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,713,806 shares.
The largest 10 holders included
JOHNSON & JOHNSON, SUVRETTA CAPITAL MANAGEMENT, LLC, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, Versant Venture Management, LLC, SECTORAL ASSET MANAGEMENT INC, FMR LLC, HHLR ADVISORS, LTD., Samsara BioCapital, LLC, and VANGUARD GROUP INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.